Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yu Yang

27PUBLICATIONS
37CO-AUTHORS
Micro- and nanosystemsBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

Sort by Publication Date:
|Apr 07, 2026
Cell Membrane Biomimetic Single-Atom Nanozymes for Combined Tumor Chemodynamic Therapy and Immunotherapy.

Bo Tian, Min Gao, Wei Yao

|Mar 19, 2026
Bioinspired IgM-Mimetic Polyvalent Aptamer-Albumin Nanoplatform for Targeted Intravesical Therapy of Bladder Cancer.

Wei Yao, Wencheng Shen, Huayuan Zhou

|Feb 24, 2026
Aptamer-Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer.

Jiayi Wang, Xuan Wang, Xinfeng Dai

|Jan 17, 2026
Manganese-Coordinated Polyvalent Aptameric System (COMPASS) Enables DC-Targeted mRNA/Mn<sup>2</sup> <sup>+</sup> Co-Delivery for Cancer Immunotherapy.

Xueliang Liu, Yuqing Li, Xinfeng Dai

|Aug 04, 2025
Single-Atom Enzymes: From Evolutionary Insights, Precision Engineering to Breakthroughs in Biomedical Applications.

Ye Xu, Chuhuang Dong, Xueliang Liu

|Oct 28, 2024
Polyvalent Aptamer Nanodrug Conjugates Enable Efficient Tumor Cuproptosis Therapy Through Copper Overload and Glutathione Depletion.

Shuang Wang, Xueliang Liu, Dali Wei

Pageof 5

Frequent Collaborators

12 joint publications

Weihong Tan

6 joint publications

Zhuang Liu

3 joint publications

Dongsheng Mao

2 joint publications

Liping Qiu

2 joint publications

Xiaoli Zhu

2 joint publications

Tongkai Chen

2 joint publications

Guifang Chen

1 joint publications

Daixin Ye

1 joint publications

Xiaohao Liu

1 joint publications

Liucun Zhu

Frequent Collaborators

12 joint publications

Weihong Tan

6 joint publications

Zhuang Liu

3 joint publications

Dongsheng Mao

2 joint publications

Liping Qiu

Top Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.2K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.9K
Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

1.8K
See more related videos

Top Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on : Jun 13, 2014

17.2K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.9K
Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

1.8K
See more related videos